PHIO PHARMACEUTICALS CORP. Adjustments to Additional Paid in Capital, Other
PHIO PHARMACEUTICALS CORP. (PHIO) reported Adjustments to Additional Paid in Capital, Other of $699.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-28.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2014-03-28
- PHIO PHARMACEUTICALS CORP. adjustments to additional paid in capital, other for fiscal 2012 was $699.00K, a 66.03% decline from fiscal 2011.
- PHIO PHARMACEUTICALS CORP. adjustments to additional paid in capital, other for fiscal 2011 was $2.06M.
| Period end | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|
| 2012-12-31 | $699.00K 10-K · filed 2014-03-28 |
| 2011-12-31 | $2.06M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |